Eric Jacobson

JULY 8, 2024

Revolutionize health care, making individualized, targeted pharmaceuticals more affordable. Kahn explains that if not carefully designed and vigilantly regulated AI will deepen income inequality, depressing wages while imposing winner-take-all markets across much of the economy.

Tacit Knowledge 81

Tacit Knowledge Competitive Advantage Pharmaceuticals Magazine 81

Strategy Driven

APRIL 3, 2014

Crafting and writing a branded healthcare executive resume, that differs from the traditional medical resume, can make a significant difference in your executive job search results and improve the opportunities to land that next-level position in pharmaceutical, biotech and medical device industries. You must appeal to all of these audiences.

Tactics 51

Tactics Execution Pharmaceuticals Human Capital 51

The Horizons Tracker

SEPTEMBER 10, 2021

By contrast, firms operating in areas such as online retail, pharmaceuticals, and information and communications technology, have all thrived. Smaller firms were especially affected by the virus because they rely far more on face-to-face interactions with customers for both marketing and transactions. Face-to-face interactions.

Pharmaceuticals 54

Pharmaceuticals Transportation Retail Long-term 54

The Horizons Tracker

FEBRUARY 22, 2022

It’s a market that is already worth $3.1 billion and is estimated to be worth $48 billion by 2026, with the Covid pandemic driving growth, especially in the healthcare and pharmaceutical industries, but also in sectors such as automotive and defense. “ There are cases with upload speeds of over 1Gbps.

Stephenson 109

Stephenson Wireless Christensen Automotive 109

Strategy Driven

JULY 13, 2011

It turned out that the unit was driving profits by raising prices and cutting marketing and advertising expenditures. Higher prices and reduced advertising created an opening for competitors to take away market share, which they did. So while profits were rising and ROIC was high, market share was declining.

ROIC 62

ROIC Balanced Scorecard Metrics McKinsey 62

Strategy Driven

JUNE 22, 2018

When your operational and back office processes are aligned you work efficiently and productively. By adapting your marketing strategy, you will be able to target new audiences for your products and services. Let’s look at the niche markets that you can tap into boost your business’s growth and profitability: Seniors.

Audience 50

Audience Niche Marketing How To Marketing Strategy 50

Strategy Driven

JANUARY 24, 2011

Execution Gap Maker #2: Nokia Nokia’s share of the worldwide market for mobile phones continued to slip in 2010. Why was this once-dominant player unable to execute and maintain its market position? This is a book for the times we live in—and one that for many companies could mean the difference between success and failure.

Execution 67

Execution Company 360-Degree Feedback Cooper 67

Strategy Driven

MARCH 18, 2011

In The Essential Advantage : How to Win with a Capabilities-Driven Strategy , Booz & Company’s Paul Leinwand and Cesare Mainardi maintain that success in any market accrues to firms with a coherence premium – a tight match between their strategic direction and the capabilities that make them unique. Let’s go after it.”

Resources 51

Resources Industry System Strategy 51

Harvard Business Review

FEBRUARY 17, 2011

Venture capitalists are increasingly interested in emerging markets, and in working with local funds based in those markets (despite the fact that reverse innovation in venture capital seems counterintuitive). In contrast, emerging-market VCs such as Nadathur Holdings (established in 2000 by N.S.

Marketing 15

Marketing Venture Capitalist Biotechnology IPO 15

Harvard Business Review

MAY 20, 2014

financial services sector went from 13,000 of independent banks to half that number, while the top ten banks grew from 20% market share to 60%. As of 2013, the top ten banks had 70% of the market. In pharmaceuticals, the largest company, Pfizer, is the result of decades of mergers. In the guitar business , too.

Pharmaceuticals 14

Pharmaceuticals Banking Chemicals Entrepreneur 14

Harvard Business Review

NOVEMBER 9, 2011

COOs are relatively common in service industries such as financial services, energy, information technology and telecommunications, but in manufacturing sectors — such as automotive, chemical, and pharmaceutical companies — they are relatively rare. What do you think?

COO 15

COO Sample Telecommunications Automotive 15

Harvard Business Review

MAY 26, 2016

Operating margins for firms publicly listed in the US show a substantial and sustained rise. Firms engage in political “rent seeking”—lobbying for regulations that provide them sheltered markets—rather than competing on innovation. Profits are up. Corporate valuations are up as well.

Pharmaceuticals 14

Pharmaceuticals Politics Price Chemicals 14

Harvard Business Review

MARCH 11, 2013

And today the company has become more open in a number of areas, as the pressures of the market forces are forcing it to open up even further. That can be a powerful marketing technique if you have the market muscle to pull it off. That can be a powerful marketing technique if you have the market muscle to pull it off.

Supply Chain 17

Supply Chain Open-book Software Niche Marketing 17

Harvard Business Review

MAY 16, 2011

True collaboration always has open-ended elements — ranging from precisely how new innovations will be implemented, to how products will fare in the market, and even to what priorities partners will pursue in the face of changes in the environment. Google uses a different approach to working with multiple external parties.

Software 19

Software Licensing Long-term Telecommunications 19

Harvard Business Review

JULY 8, 2016

The difference between displacement (outperforming existing market incumbents at their own game) and disruption (changing the game) is strategically important, no matter how similar the pain they cause is. Drucker Forum 2016: The Entrepreneurial Society. Displacement generally is easier to combat than disruption.

Business Model 14

Business Model Innovation Company Apparel 14

Harvard Business Review

MARCH 2, 2012

As global companies focus their strategies on developed and emerging markets, they require substantial cadres of leaders capable of operating effectively anywhere in the world. economy, expands America's global trade, and attracts foreign companies to base operations in the U.S.

Competitive Advantage 16

Competitive Advantage Globalization Development Intellectual Capital 16

Harvard Business Review

APRIL 16, 2012

To enhance financial flexibility, companies have been retaining unprecedented amounts of cash on their balance sheets, calling it "strategic" cash to distinguish it from the "operating" cash that is needed to run the business. high technology or pharmaceutical) that are investing in projects with uncertain long-range payoffs.

Company 15

Company Cost of Capital Finance Long-term 15

Harvard Business Review

FEBRUARY 6, 2018

Consider its decision to pursue the market for pharmaceutical distribution, or the recent announcement that it will be teaming up with Berkshire Hathaway and JP Morgan Chase to create joint solutions for reducing the health care spending of more than 1 million employees and their families. .”

Health Care 15

Health Care Retail Operations Insurance 15

Harvard Business Review

JULY 7, 2011

Many of the best leaders and managers in the business world operate from the Pleaser power style. When they are operating from their strengths, Pleasers can become the glue that holds a positive corporate culture together. Roger, a vice president of sales and marketing in the pharmaceutical industry, was one such Pleaser.

Rogers 16

Rogers Morale Long-term Pharmaceuticals 16

Harvard Business Review

SEPTEMBER 29, 2011

They can signal to the market the types of investors they wish to own their shares. In Scandinavia, some families hold on to their investments — many of which are listed on stock exchanges — for generations. CEOs can seek to attract long-term investors in several ways: 1. Take consumer goods giant Unilever.

Long-term 15

Long-term CEO Short-term Asset Management 15

Harvard Business Review

JULY 30, 2015

A new research report from the Society of Digital Agencies finds that in the past year there has been a dramatic spike in the number of companies who no longer work with outside marketing agencies — 27 percent, up from 13 percent in the previous year. Marketing activities today generate unprecedented amounts of data.

Marketing 8

Marketing Advertising Trends Brand 8

Harvard Business Review

OCTOBER 6, 2016

Barbara Kellerman from Harvard, Jeffrey Pfeffer from Stanford, and numerous other experts have pointed out that the development market is filled with fads — slick behavioral models and fun, engaging tools — that don’t really move the needle. But there’s little evidence that much of this works. Insight Center.

Leadership Pipeline 15

Leadership Pipeline Leadership After Action Review Pharmaceuticals 15

Harvard Business Review

SEPTEMBER 26, 2011

The stock market is short-term-oriented. The market favorably receives projects with long-term payoffs, particularly those in research and development. Some people may contend that given the high risks and many years it takes to develop a new drug, pharmaceutical companies are different animals from other firms. I disagree.

CEO 17

CEO Short-term Long-term Pharmaceuticals 17

Harvard Business Review

SEPTEMBER 14, 2011

We recently visited the brand-new R&D lab of Dr Reddy's , one of India's leading pharmaceutical firms. Dr Reddy's plan is to leverage Chirotech's scientific capabilities to optimize drug development processes, thus lowering manufacturing costs and speeding time-to-market. Cambridge, U.K. facility in Cambridge Science Park. and the U.K.

Globalization 12

Globalization Innovation Decentralization Chemicals 12

Harvard Business Review

JANUARY 8, 2013

arm of pharmaceuticals manufacturer Boehringer Ingelheim (BIPI). He emailed Christopher Tan, a marketer with an interest in mobile technologies and experience building applications, and within 36 hours, they had come up with a prototype. But, as we all know, bridging interdepartmental chasms is far easier said than done.

Company 13

Company Pharmaceuticals Health Care Participative 13

Harvard Business Review

AUGUST 8, 2018

As chief executive from 1972 to 1994, Richard Gelb (HBS, 1950) orchestrated Bristol-Myers’ acquisition of Squibb and transformed the firm from a personal care company to a diversified pharmaceutical giant. ” The thinking on diversification later changed, turning into skepticism in the 1970s and outright criticism in the 1980s.

Influence 15

Influence Education Pharmaceuticals CEO 15

Harvard Business Review

JANUARY 31, 2013

First we see major shifts in demand: developing economies such as China and India are morphing from the world's source of low-cost manufacturing capacity to the world's best market opportunities. Pharmaceutical companies are mastering bio-engineering techniques that will help develop personalized medicines.

Globalization 12

Globalization Supply Chain Pharmaceuticals McKinsey 12

Harvard Business Review

JULY 12, 2011

Microsoft and Intel, as is well known, have long sought alternatives to their being fused at the hip — Microsoft seeking alternative chip platforms for its software, and Intel supporting additional operating systems. PDF) But that would leave you out of the game for many new technologies and markets, where alliances are essential.

Management 14

Management Airlines How To Pharmaceuticals 14

Harvard Business Review

OCTOBER 24, 2014

In addressing the billion-dollar adherence problem, Vitality (since acquired by NANTHEALTH ) considered the interests of the players in the diverse ecosystem, including pharmaceutical companies, retail pharmacies, and health care providers. Operations. Information & technology Operations Organizational culture Product development'

Productivity 11

Productivity Products Company Engineering 11

Harvard Business Review

AUGUST 3, 2016

On the other hand, M&As can also strengthen the market power of the combined entity, reducing competition in a way that harms consumers. This is especially true in pharmaceutical markets where new and affordable drugs can improve and even save the lives of many people. What’s the reason for this?

Innovation 8

Innovation Pharmaceuticals Company Price 8

Harvard Business Review

OCTOBER 24, 2017

These have forced AirBnB, Tesla, and Uber to make costly concessions to their operating practices or to exit certain markets altogether. The petition was seen as instrumental in getting the city council to adopt new regulations which permitted Uber to operate legally. In the U.S.,

Licensing 14

Licensing Proposal Retail Long-term 14

Harvard Business Review

JUNE 14, 2017

And ease of access means ease of market entry: Emerging data providers can get on their feet quickly and create new sources of competition. The bulk of HCIT investment supports startups that sell data — clinical or operational information that is otherwise difficult for clients to obtain or to organize. demographics.

Health Care 12

Health Care Levitt Competitive Advantage Pharmaceuticals 12

Harvard Business Review

OCTOBER 25, 2018

Traditionally, organizations have used data analytics as a tool of retrospection, as a means of answering questions like, “Did this marketing campaign reach our desired audience?” ” or “Who were our highest-value customers over the last year?” ” moments than would otherwise arise.

How To 15

How To Pharmaceuticals Process Organization 15

Harvard Business Review

MARCH 27, 2018

Apple and Google, for example, each control a popular mobile phone operating system platform (and key apps on that platform), Amazon controls the largest online merchant platform, and Facebook controls the largest social network platform. He noted his agency’s “particular concerns in digital markets.” In the U.S.,

Company 15

Company Advertising Incentives Price 15

Harvard Business Review

DECEMBER 18, 2014

It used to be that hospitals and health systems operated as islands, selecting and purchasing medical supplies, devices and medications in isolation, and keeping their operational and leadership practices to themselves. While collaboration is always challenging, the health care benefits are by now clear.

Health Care 9

Health Care Retail Mayo Pharmaceuticals 9

Harvard Business Review

OCTOBER 23, 2014

That’s why pharmaceutical, biotechnology, and medical device companies need to define their relevance in this new health care ecosystem, and soon. They’re also sharing risk. The new business model has yet to solidify, and the leaders have yet to emerge. The positions are there for the taking. But not for long. The options are tangible.

Health Care 9

Health Care Pharmaceuticals Information Technology Supply Chain 9

Harvard Business Review

MAY 10, 2013

As noted management expert Geoffrey Moore told me with respect to high-velocity competition, "I''m not sure you ever want to be in the public markets." Its RAZR thin phone was a huge success in the mid-2000''s, and the market raved. Take Motorola, for instance. Take Motorola, for instance. So we are left with a quandary.

Venture Capitalist 10

Venture Capitalist Competitive Advantage Restructuring Short-term 10